Some evidence for liquid biopsy identification of RB1 in other cancers exists, primarily focusing on retinoblastoma (aqueous humor cfDNA [156]), but emerging evidence also exists for bladder urothelial carcinoma (urinary cfDNA and exosomes) [157]. Here, RB1 is linked to bladder transitional cell carcinoma.